Annually, out-of-pocket costs paid by 86.5 to 95.2 percent of patients for evaluation/management visits
WEDNESDAY, Dec. 23 2020 (HealthDay News) — From 2001 to 2016, out-of-pocket costs of evaluation and management (E/M) services and common diagnostic tests increased for neurology patients, according to a study published online Dec. 23 in Neurology.
Chloe E. Hill, M.D., from the University of Michigan in Ann Arbor, and colleagues used a large, privately insured health care claims database to measure out-of-pocket costs for E/M services and common diagnostic testing for neurology patients from 2001 to 2016. Data were included for 3,724,342 patients.
The researchers found that E/M visits, electromyogram/nerve conduction studies , magnetic resonance imaging (MRI), and electroencephalograms (EEGs) were the most frequent neurologic services (78.5, 7.7, 5.3, and 4.5 percent, respectively). Annually, out-of-pocket costs were paid by 86.5 to 95.2 percent of patients for E/M visits and by 23.1 to 69.5 percent of patients for diagnostic tests. The mean out-of-pocket cost increased over time, with the most substantial increases seen for EEG, MRI, and E/M visits. There was considerable variation noted in out-of-pocket costs; the 50th and 95th percentile paid $103.1 and $875.4, respectively, for an MRI in 2016. The investigators also observed an increase in the proportion of total service cost paid out of pocket.
“This trend of increased out-of-pocket costs could be harmful, as people may forgo diagnostic evaluation due to costs, or those who complete diagnostic testing may be put in a position of financial hardship before they can even start to treat their condition,” Hill said in a statement.
Several authors disclosed financial ties to the medical device and medical-legal industries.
Abstract/Full Text (subscription or payment may be required)
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Addition of CAC to PREVENT-ASCVD Equations May Improve Predictive Utility in Certain Patients
1 in 4 Former NFL Players Had CTE at Death in 2016 to 2021
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy
Frequent TV Watching Linked to Smaller Brain Volume
ADHD Poses Additional Concussion Challenges for Athletes
High Levels of Light Exposure Linked to Lower Dementia Risk